
|Articles|July 11, 2012
Drug Cost Control in Oncology
Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
3
Trial Data Yield Risk-Based NRSTS Treatment Strategies
4
Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL
5














































